Repurposing drugs for COVID-19: Pharmacokinetics and pharmacogenomics of chloroquine and hydroxychloroquine
M Babayeva, Z Loewy - Pharmacogenomics and personalized …, 2020 - Taylor & Francis
Background A new coronavirus SARS-CoV-2 has been identified as the etiological agent of
the severe acute respiratory syndrome, COVID-19, the source and cause of the 2019–20 …
the severe acute respiratory syndrome, COVID-19, the source and cause of the 2019–20 …
Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients
GM Raj, J Mathaiyan, M Wyawahare… - Drug Metabolism and …, 2018 - degruyter.com
Background This work aimed to evaluate the influence of single nucleotide polymorphisms
(SNPs) in the SLC47A1 (922-158G> A; rs2289669) and SLC47A2 (− 130G> A; rs12943590) …
(SNPs) in the SLC47A1 (922-158G> A; rs2289669) and SLC47A2 (− 130G> A; rs12943590) …
Status of pharmacogenomics research in India during the last five years
R Priyadarshini, GM Raj, DG Shewade - 2018 - insajournal.in
Studies related to pharmacogenomics have considerably increased in recent years in India.
The interests shown by our researchers are largely reflecting the global trend towards the …
The interests shown by our researchers are largely reflecting the global trend towards the …
[PDF][PDF] SLC47A1 基因型在预测二甲双胍治疗2 型糖尿病疗效中的应用
张文， 栾家杰， 刘俊， 许慧芳， 杨魁， 赵咏莉… - 临床与病理 …, 2020 - cdn.amegroups.cn
目的: 分析SLC47A1 (rs2289669) 基因型在预测二甲双胍治疗2 型糖尿病(type 2 diabetes
mellitus, T2DM) 疗效中的价值. 方法: 回顾性采集2019 年4 月至2020 年1 …
mellitus, T2DM) 疗效中的价值. 方法: 回顾性采集2019 年4 月至2020 年1 …
Multidrug and toxin extrusion proteins
LM Aleksunes, V Woo, MS Joy - Drug Transporters: Molecular …, 2022 - Wiley Online Library
Multidrug and toxic compound extrusion (MATE) proteins are responsible for the efflux of
cationic chemicals across cell membranes. In humans, there are two orthologs …
cationic chemicals across cell membranes. In humans, there are two orthologs …